CN108138362B - 模块化多肽文库以及其制备和使用方法 - Google Patents

模块化多肽文库以及其制备和使用方法 Download PDF

Info

Publication number
CN108138362B
CN108138362B CN201680057253.XA CN201680057253A CN108138362B CN 108138362 B CN108138362 B CN 108138362B CN 201680057253 A CN201680057253 A CN 201680057253A CN 108138362 B CN108138362 B CN 108138362B
Authority
CN
China
Prior art keywords
domain
library
protein
modular
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201680057253.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN108138362A (zh
Inventor
W·A·林
S·M·科伊尔
R·M·歌德雷
K·T·罗伊鲍尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Priority to CN202210290324.8A priority Critical patent/CN114657173A/zh
Publication of CN108138362A publication Critical patent/CN108138362A/zh
Application granted granted Critical
Publication of CN108138362B publication Critical patent/CN108138362B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/421—Immunoglobulin superfamily
    • A61K40/4211—CD19 or B4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
CN201680057253.XA 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法 Expired - Fee Related CN108138362B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210290324.8A CN114657173A (zh) 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562212999P 2015-09-01 2015-09-01
US62/212,999 2015-09-01
PCT/US2016/049745 WO2017040694A2 (en) 2015-09-01 2016-08-31 Modular polypeptide libraries and methods of making and using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202210290324.8A Division CN114657173A (zh) 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法

Publications (2)

Publication Number Publication Date
CN108138362A CN108138362A (zh) 2018-06-08
CN108138362B true CN108138362B (zh) 2022-03-29

Family

ID=58188233

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201680057253.XA Expired - Fee Related CN108138362B (zh) 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法
CN202210290324.8A Pending CN114657173A (zh) 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202210290324.8A Pending CN114657173A (zh) 2015-09-01 2016-08-31 模块化多肽文库以及其制备和使用方法

Country Status (14)

Country Link
US (2) US11560561B2 (https=)
EP (3) EP3344803B1 (https=)
JP (2) JP6878408B2 (https=)
KR (2) KR102659574B1 (https=)
CN (2) CN108138362B (https=)
AU (2) AU2016315941B2 (https=)
CA (2) CA3227545A1 (https=)
EA (1) EA201890611A1 (https=)
ES (1) ES2887593T3 (https=)
IL (2) IL293963A (https=)
MX (2) MX393983B (https=)
PT (1) PT3344803T (https=)
SG (1) SG10201913915WA (https=)
WO (1) WO2017040694A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2875747T3 (es) 2016-01-11 2021-11-11 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia
WO2017123559A2 (en) 2016-01-11 2017-07-20 The Board Of Trustees Of The Leland Stanford Junior University Chimeric proteins and methods of regulating gene expression
WO2019020733A1 (en) * 2017-07-26 2019-01-31 Cellectis METHODS OF IMMUNE CELL SELECTION OF THE ANTIGEN-DEPENDENT CHIMERIC ANTIGENIC RECEPTOR (CAR)
WO2020036181A1 (ja) * 2018-08-13 2020-02-20 Ｓｐｉｂｅｒ株式会社 細胞を単離又は同定する方法及び細胞集団
KR20210060541A (ko) * 2018-09-19 2021-05-26 더 유니버시티 오브 홍콩 개선된 고처리량 조합 유전적 변형 시스템 및 최적화된 Cas9 효소 변이체
GB201816522D0 (en) 2018-10-10 2018-11-28 Autolus Ltd Methods and reagents for analysing nucleic acids from single cells
US20220017894A1 (en) * 2018-11-06 2022-01-20 Gordian Biotechnology, Inc. Compositions and methods for in vivo screening of therapeutics
CN109576292B (zh) 2018-12-21 2022-11-29 深圳市爱思迪生物科技有限公司 一种抗体文库的构建方法及其应用
JP6821230B2 (ja) * 2019-02-04 2021-01-27 国立大学法人愛媛大学 ＣＡＲライブラリおよびｓｃＦｖの製造方法
US20200325241A1 (en) * 2019-04-11 2020-10-15 Massachusetts Institute Of Technology Novel chimeric antigen receptors and libraries
AU2020265583A1 (en) * 2019-04-28 2021-12-02 Earlydiagnostics, Inc. Methods for library preparation to enrich informative DNA fragments using enzymatic digestion
US20220396609A1 (en) * 2019-11-01 2022-12-15 Senti Biosciences, Inc. Chimeric receptor sensors
CN111304244A (zh) * 2019-11-13 2020-06-19 沣潮医药科技（上海）有限公司 携带基因元件组合的载体组件、受体细胞文库、制备和筛选方法及用途
US11739370B1 (en) 2020-01-10 2023-08-29 Gordian Biotechnology, Inc. Methods and compositions for in vivo screening of therapeutics through spatial transcriptomics
CN114057890A (zh) * 2020-07-31 2022-02-18 南京北恒生物科技有限公司 新型共刺激结构域及其用途
CA3255881A1 (en) 2022-06-17 2023-12-21 Insitro, Inc. In situ sequencing of RNA transcripts with non-uniform 5' ends
JP2026009432A (ja) * 2022-09-20 2026-01-21 Ｓｐｉｂｅｒ株式会社 Ｄｎａ配列のスクリーニング方法
WO2025054202A1 (en) * 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
WO2025054284A1 (en) * 2023-09-06 2025-03-13 Baylor College Of Medicine Refinement of car constructs via barcoded screening
CN120865430A (zh) * 2024-04-30 2025-10-31 合源生物科技(天津)有限公司 一种增强型嵌合抗原受体及其应用
CN119264271B (zh) * 2024-10-08 2025-05-09 北京市神经外科研究所 一种nk细胞特异性的嵌合抗原受体及其应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1610737A (zh) * 2001-12-07 2005-04-27 图尔金株式会社 嵌合蛋白质的表型筛选
CN101548034A (zh) * 2006-10-02 2009-09-30 航道生物技术有限责任公司 多样性合成肽和多肽文库的设计和构建
WO2012041802A1 (en) * 2010-09-29 2012-04-05 Deutsches Krebsforschungszentrum Means and methods for improved protein interaction screening
WO2012112804A1 (en) * 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
WO2014127261A1 (en) * 2013-02-15 2014-08-21 The Regents Of The University Of California Chimeric antigen receptor and methods of use thereof
CN104769103A (zh) * 2012-09-04 2015-07-08 塞勒克提斯公司 多链嵌合抗原受体和其用途
WO2015123642A1 (en) * 2014-02-14 2015-08-20 Board Of Regents, The University Of Texas System Chimeric antigen receptors and methods of making

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR587222A (fr) 1923-12-21 1925-04-14 Rhodiaseta Perfectionnements dans les procédés et appareils destinés à la fabrication des fis ou filaments artificiels
US20090233806A1 (en) 1999-07-06 2009-09-17 Carr Francis J Protein isolation and analysis
US20040121324A1 (en) 2001-01-18 2004-06-24 Brenner Charles M. Barcoded synthetic lethal screening to identify drug targets
US7604805B2 (en) 2003-07-03 2009-10-20 Regents Of The University Of California Protein logic gates
AU2005250408B2 (en) * 2004-05-27 2010-09-23 The Trustees Of The University Of Pennsylvania Novel artificial antigen presenting cells and uses therefor
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
US9051665B2 (en) * 2008-11-20 2015-06-09 Steven L. Zeichner Method for screening biomolecules
CA2821299C (en) * 2010-11-05 2019-02-12 Frank J. Steemers Linking sequence reads using paired code tags
SG11201406538VA (en) * 2012-04-13 2014-11-27 Sequenta Inc Detection and quantitation of sample contamination in immune repertoire analysis
US20150011405A1 (en) 2013-07-03 2015-01-08 Atreca, Inc. Use of Nanoexpression to Interrogate Antigen Repertoires
WO2015163745A1 (ko) * 2014-04-25 2015-10-29 재단법인 의약바이오컨버젼스연구단 바코드 이동 분석을 위한 이중 리포터 시스템을 보유한 효모 균주
US20150315569A1 (en) * 2014-05-02 2015-11-05 The Board Of Trustees Of The Leland Stanford Junior University Method for screening a nucleic acid-programmed small molecule library

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1610737A (zh) * 2001-12-07 2005-04-27 图尔金株式会社 嵌合蛋白质的表型筛选
CN101548034A (zh) * 2006-10-02 2009-09-30 航道生物技术有限责任公司 多样性合成肽和多肽文库的设计和构建
WO2012041802A1 (en) * 2010-09-29 2012-04-05 Deutsches Krebsforschungszentrum Means and methods for improved protein interaction screening
WO2012112804A1 (en) * 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
CN104769103A (zh) * 2012-09-04 2015-07-08 塞勒克提斯公司 多链嵌合抗原受体和其用途
WO2014127261A1 (en) * 2013-02-15 2014-08-21 The Regents Of The University Of California Chimeric antigen receptor and methods of use thereof
WO2015123642A1 (en) * 2014-02-14 2015-08-20 Board Of Regents, The University Of Texas System Chimeric antigen receptors and methods of making

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Design and development of therapies using chimeric antigen receptor-expressing T cells;Gianpietro Dotti等;《Immunol Rev》;20131213;第257卷(第1期);全文 *
Engineering T cell function using chimeric antigen receptors identified using a DNA library approach;Connie P M Duong等;《PLoS One》;20130507;第8卷(第5期);第8页右栏第2-4段、第9页左栏第2段-右栏第6段 *
Isolation of tumor antigen-specific single-chain variable fragments using a chimeric antigen receptor bicistronic retroviral vector in a Mammalian screening protocol;Grazyna Lipowska-Bhalla等;《Hum Gene Ther Methods》;20130912;第24卷(第6期);全文 *
表达靶向癌胚抗原的嵌合受体的慢病毒载体构建及初步应用;余晓玲等;《第三军医大学学报》;20150615;第37卷(第11期);全文 *

Also Published As

Publication number Publication date
US12460199B2 (en) 2025-11-04
AU2016315941A1 (en) 2018-03-08
WO2017040694A3 (en) 2017-04-20
WO2017040694A2 (en) 2017-03-09
MX2022007861A (es) 2022-07-19
KR102659574B1 (ko) 2024-04-23
JP2018525992A (ja) 2018-09-13
HK1256697A1 (zh) 2019-10-04
IL293963A (en) 2022-08-01
JP6878408B2 (ja) 2021-05-26
EP3344803B1 (en) 2021-08-04
CN114657173A (zh) 2022-06-24
HK1256838A1 (en) 2019-10-04
AU2022275510A1 (en) 2023-01-19
ES2887593T3 (es) 2021-12-23
MX2018002596A (es) 2019-02-07
EP3954772B1 (en) 2023-10-25
IL257453B (en) 2022-07-01
IL257453A (en) 2018-04-30
US11560561B2 (en) 2023-01-24
KR20240056636A (ko) 2024-04-30
PT3344803T (pt) 2021-09-20
EP4282979A2 (en) 2023-11-29
US20200224191A1 (en) 2020-07-16
EP3954772C0 (en) 2023-10-25
CA2995389A1 (en) 2017-03-09
EP3954772A1 (en) 2022-02-16
EP4282979A3 (en) 2024-02-28
EP3344803A4 (en) 2019-06-12
AU2016315941B2 (en) 2022-09-08
JP7397821B2 (ja) 2023-12-13
EP3344803A2 (en) 2018-07-11
CA3227545A1 (en) 2017-03-09
SG10201913915WA (en) 2020-03-30
JP2021119780A (ja) 2021-08-19
EA201890611A1 (ru) 2018-08-31
KR20180081486A (ko) 2018-07-16
CN108138362A (zh) 2018-06-08
US20230212557A1 (en) 2023-07-06
CA2995389C (en) 2024-03-12
MX393983B (es) 2025-03-24

Similar Documents

Publication Publication Date Title
US12460199B2 (en) Modular polypeptide libraries and methods of making and using same
US20240084253A1 (en) Method of assessing activity of recombinant antigen receptors
JP2021182942A (ja) タンパク質をゲノム内の特定の遺伝子座に導くための組成物および方法
JP5537420B2 (ja) 標的遺伝子の誘導性変異誘発
JPH05501348A (ja) あらかじめ選択された特異性を有するレセプターを単離する方法
HK40104037A (en) Modular polypeptide libraries and methods of making and using same
HK40069214A (en) Modular polypeptide libraries and methods of making and using same
HK40067078A (en) Modular polypeptide libraries and methods of making and using same
HK40069214B (en) Modular polypeptide libraries and methods of making and using same
HK1256697B (en) Modular polypeptide libraries and methods of making and using same
US20100203509A1 (en) Inducible fluorescently-tagged protein expression system
HK1256838B (en) Modular polypeptide libraries and methods of making and using same
EA046546B1 (ru) Библиотеки модульных полипептидов и способы их получения и применения
EA041085B1 (ru) Библиотеки модульных полипептидов и способы их получения и применения
WO2026006919A1 (en) Method for the generation of large, multispecific antibody libraries and applications for ultra-high-throughput functional screening
Wen Cell surface display in biomedical applications and biofuels production
Zeller Jr Transcriptional control of spatially regulated genes in the early sea urchin embryo

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1256697

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220329